AF-399 42016530
Modify Date: 2025-09-24 21:58:02
AF-399 42016530 structure
|
Common Name | AF-399 42016530 | ||
|---|---|---|---|---|
| CAS Number | 618864-56-5 | Molecular Weight | 531.619 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H17N3O4S3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AF-399 42016530A potent CCR4 antagonist that blocked CCL22- and CCL17-mediated migration of human peripheral blood CD4+CD25+ Treg and Th2 cells ex-vivo and murine Tregs in-vivo; enhances DC-mediated human CD4(+) T cell proliferation in an in vitro immune response model and amplifies cellular and humoral immune responses in vivo in experimental models, induces antigen-specific CD8+ T cells and tumor immunity against self antigens in combination with vaccines. |
| Name | AF-399 42016530 |
|---|
| Description | A potent CCR4 antagonist that blocked CCL22- and CCL17-mediated migration of human peripheral blood CD4+CD25+ Treg and Th2 cells ex-vivo and murine Tregs in-vivo; enhances DC-mediated human CD4(+) T cell proliferation in an in vitro immune response model and amplifies cellular and humoral immune responses in vivo in experimental models, induces antigen-specific CD8+ T cells and tumor immunity against self antigens in combination with vaccines. |
|---|---|
| References | References 1. Klein A, et al. Oncotarget. 2017 May 9;8(19):31079-31091. 2. Bayry J, et al. Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10221-6. 3. Pere H, et al. Blood. 2011 Nov 3;118(18):4853-62. View Related Products by Target Chemokine Receptor (CCR and CXCR) |
| Molecular Formula | C26H17N3O4S3 |
|---|---|
| Molecular Weight | 531.619 |
| InChIKey | WRLPSJVPFIQMMC-UHFFFAOYSA-N |
| SMILES | O=C(C1=C(O)C(=O)N(c2nnc(SCc3ccccc3)s2)C1c1cccs1)c1cc2ccccc2o1 |